IL13 and allergic rhinitis: In an allergic rhinitis mouse model, SHEDs inhibited the Th2 immune response by downregulating IL-4, IL-5, and IL-13 levels in spleen lymphocytes and decreasing the production of serum IgE and IgG1 [14].